ArticleClinical cardiology2020

Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.

Maria Tafelmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.